These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6794141)

  • 1. Hematologic and cytogenetic effects of androgens in cytostatic-treated mice (the micronucleus test).
    Ioan D
    Endocrinologie; 1981; 19(3):179-81. PubMed ID: 6794141
    [No Abstract]   [Full Text] [Related]  

  • 2. The mutagenic effect of 131I and of two cytostatics revealed by the micronucleus test (MT).
    Ioan D; Petrescu M; Maximilian C
    Endocrinologie; 1977; 15(2):119-22. PubMed ID: 405734
    [No Abstract]   [Full Text] [Related]  

  • 3. Nucleus anomaly test and chromosomal analysis of bone marrow cells of the Chinese hamster and dominant lethal test in male mice after treatment with fluorescent whitening agents.
    Müller D; Fritz H; Langauer M; Strasser FF
    Environ Qual Saf Suppl; 1975; 4():247-63. PubMed ID: 1064545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stem cell kinetics of bone marrow in relation to cytostatic treatment].
    Laerum OD
    Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1207-9 passim. PubMed ID: 4935674
    [No Abstract]   [Full Text] [Related]  

  • 5. [Morphological aspects of the action of antimitotic drugs on the reticuloendothelial system: the giant histiocytic cells].
    Castaldi G; Zavagli G; Fiocchi O; Trotta F
    Haematologica; 1969; 54(5):297-317. PubMed ID: 4993365
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disturbances of mitotic activity in hemohistoblasts of the bone marrow during acute radiation injury and under the effects of chemical mutagenic agents].
    Gol'dberg ED; Gol'dberg DI; Golubev IV
    Arkh Patol; 1967; 29(2):25-30. PubMed ID: 4973501
    [No Abstract]   [Full Text] [Related]  

  • 7. [The cytogenetic effects of antitumor preparations with different mechanisms of action].
    Khlusova MIu; Novitskiĭ VV; Gol'dberg ED
    Eksp Klin Farmakol; 1992; 55(2):49-52. PubMed ID: 1422456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo cytogenetic screening for determination of the mutagenic potential of cyclophosphamide.
    Barbărasă C; Luca D; Postică F; Covic M
    Morphol Embryol (Bucur); 1979; 25(4):369-72. PubMed ID: 160994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavior of marrow stem cells in irradiated and non-irradiated mice after treatment with cytotoxic agents.
    Berman I; McCabe B; Dauer MM
    Radiat Res; 1969 May; 38(2):296-306. PubMed ID: 4977149
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of combined cytoxic agents on the bone marrow].
    Maisin H
    C R Seances Soc Biol Fil; 1966; 160(8):1740-4. PubMed ID: 4227904
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in the bone marrow cell count of mice under the combined action of ultrahigh-frequency irradiation and of antitumor preparations].
    Sevast'ianova LA; Vilenskaia RL; Kubatkina EI
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1974; 0(8):55-7. PubMed ID: 4138941
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
    Lopez M; Mary JY; Sainteny F
    Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chemotherapeutic agents on normal mouse bone marrow grown in vitro.
    Brown CH; Carbone PP
    Cancer Res; 1971 Feb; 31(2):185-90. PubMed ID: 5545269
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of claphene on marrow cell chromosomes in golden hamster (Mesocricetus auratus) in vivo].
    Constantinescu O; Iliescu A
    Arch Roum Pathol Exp Microbiol; 1971; 30(3):485-91. PubMed ID: 5150509
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytembena administered in combination with cyclophosphamide in Yoshida ascitic sarcoma.
    Veselá H; Jelínek V; Pujman V; Zlatkovská Z
    Neoplasma; 1971; 18(5):459-64. PubMed ID: 5119519
    [No Abstract]   [Full Text] [Related]  

  • 16. Ten model mutagens evaluated by the micronucleus test.
    Maier P; Schmid W
    Mutat Res; 1976 Nov; 40(4):325-37. PubMed ID: 64925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of mammalian cells against chemotherapeutic agents thiotepa, 1,3-N,N'-bis(2-chloroethyl)-N-nitrosourea, and mafosfamide using the DNA base excision repair genes Fpg and alpha-hOgg1: implications for protective gene therapy applications.
    Xu Y; Hansen WK; Rosenquist TA; Williams DA; Limp-Foster M; Kelley MR
    J Pharmacol Exp Ther; 2001 Mar; 296(3):825-31. PubMed ID: 11181913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary assessment of the cytogenetic effects of metepa on mouse bone marrow using the micronucleus test.
    Richardson JC
    Mutat Res; 1974 Oct; 26(5):391-4. PubMed ID: 4411711
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miltefosine decreases the cytotoxic effect of epirubicine and cyclophosphamide on mouse spermatogenic, thymic and bone marrow cells.
    Martinova Y; Topashka-Ancheva M; Konstantinov S; Petkova S; Karaivanova M; Berger M
    Arch Toxicol; 2006 Jan; 80(1):27-33. PubMed ID: 16079990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.